Clinical TrialsSearch results
Number of results: 823
Recruiting
- Single Administration study of Bomedemstat (MK-3543) in Healthy Japanese
- Essential thrombocythaemia
- Tanaka Yoshiyuki
- 2023-11-25
Recruiting
- A phase 2 study of chemotherapy and durvalumab with TRT in patients with ED-SCLC
- extensive disease small cell lung cancer(ED-SCLC)
- Takayama Koichi
- 2021-02-24
Other
- LOGIK2001(SPEED)
- extensive disease small Cell Lung Cancer(ED-SCLC)
- Okamoto Isamu
- 2021-06-21
Other
- phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.
- extensive disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-05
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- A Phase II study of Durvalumab (MEDI4736) plus carboplatin and etoposide in elderly patients with extensive-stage small-cell lung cancer
- extensive-stage small cell lung cancer
- Koichi Azuma
- 2021-08-05
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Gene analysis associated with short stature and growth hormone responsiveness
- famirial short stature, idopathic short stature, Noonan syndrome, and good/poor respoders of growth hormone therapy
- Keio University, School of Medicine
- 2006-12-01
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30